China, AstraZeneca
Europe's STOXX 600 eked out minor gains on Tuesday led by gains in industrials as investors assessed a slew of downbeat ...
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
The AstraZeneca PLC ADR AZN inched 0.01% higher to $71.43 Monday, on what proved to be an all-around grim trading session ...
Britain's benchmark FTSE 100 edged lower on Tuesday, hurt by AstraZeneca's fall on a potential China probe, while investors ...
In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed ...
Analyst Sachin Jain from Bank of America Securities maintained a Buy rating on AstraZeneca (AZN – Research Report) and keeping the price ...
AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The ...
The FTSE 100 finished 11.85 points, or 0.14%, lower to end the day at 8,172.39. In the US, Wall Street started trading in a ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on AstraZeneca (AZN – Research Report), with ...
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback